Form 4: InfuSystem HR Chief's Stock Vesting & Tax Sale

InfuSystem Holdings' EVP-Chief HR Officer, Jerod Funke, acquired 12,500 shares through RSU vesting and sold 3,669 shares for tax obligations.

Summary

• Jerod Funke, EVP-Chief HR Officer of InfuSystem Holdings, Inc. (INFU), reported changes in his beneficial ownership.
• On October 9, 2025, 12,500 Restricted Stock Units (RSUs) vested and converted into an equal number of common stock shares.
• These RSUs were part of a grant that vests in two equal annual installments, with the first installment on October 9, 2024.
• Following the vesting, 3,669 shares of common stock were withheld by the Issuer at a price of $9.61 per share to cover tax liabilities.
• After these transactions, Jerod Funke's direct beneficial ownership of common stock increased from 9,831 shares to 18,662 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While there's a sale of shares, it's for tax purposes, which is routine. The net effect is an increase in the officer's direct ownership, aligning executive interests with shareholders.

Positives

• The vesting of 12,500 Restricted Stock Units (RSUs) represents a scheduled compensation event for the EVP-Chief HR Officer.
• Jerod Funke's direct beneficial ownership of common stock increased by 8,831 shares (12,500 acquired minus 3,669 sold for taxes), demonstrating continued alignment with shareholder interests.

Negatives

• A portion of the vested shares (3,669 shares) was sold to cover tax liabilities, which represents a reduction in the gross number of shares acquired.

Future Outlook

The filing does not contain any forward-looking statements or guidance beyond the scheduled vesting of restricted stock units.

Management Comments

• "/s/ Kevin Whitman, Attorney-in-Fact for Jerod Funke"

Industry Context

This filing is a routine insider transaction report, common across all publicly traded companies, reflecting executive compensation practices. It does not provide specific insights into broader industry trends for healthcare technology or medical device companies.

Stakeholder Impact

• Shareholders: The increase in executive's direct ownership may be viewed positively as it aligns management's interests with long-term shareholder value. The tax-related sale is a routine event and generally has minimal impact.
• Employees: This filing reflects standard executive compensation practices, which may be part of broader employee incentive programs.

Key Dates

Keywords

InfuSystem Holdings, INFU, Jerod Funke, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Stock Ownership, Executive Compensation